Nifedipine
Nifedipine is a dihydropyridine calcium-channel blocker used mainly to treat high blood pressure and angina. Immediate-release and extended-release products differ substantially, so instructions depend on the exact formulation.
At a glance
Quick facts
- Drug class
- Dihydropyridine calcium-channel blocker
- Main uses
- Hypertension · angina
- Route
- Oral
- WHO ATC
- C08CA05
- Forms
- Modified / extended-release products
- Key interaction
- Grapefruit can increase exposure
Names & terminology
How this entity may be named or searched
- Canonical generic name
- Nifedipine
- Formulation terms
- ER · XL · extended release · prolonged release
- Brand examples
- Adalat CC · Procardia XL — market availability varies
- Important distinction
- Immediate-release capsules and extended-release tablets are not interchangeable instructions.
Structured drug profile
Drug profile
What is nifedipine?
Nifedipine is a dihydropyridine calcium-channel blocker used mainly for high blood pressure and angina; some health systems also use it for Raynaud's phenomenon.
What is nifedipine used for?
Nifedipine is used to treat hypertension and to control angina. It lowers blood pressure by relaxing arterial smooth muscle and can improve coronary blood flow. It is also used off-label in some settings for conditions such as Raynaud phenomenon or preterm labor. [1]
How nifedipine works
Nifedipine reduces calcium entry into vascular smooth muscle, relaxing arteries and lowering vascular resistance.
Forms and release systems
Modern nifedipine therapy often uses extended-release tablets. The DailyMed product cited here is designed for once-daily administration and is available in 30 mg, 60 mg and 90 mg strengths. Other formulations and markets differ, so the tablet strength alone does not define the schedule. [2]
Country / market layer
Brands & formulations by country
Selected registered products and formulations differ by market. African tabs use national regulatory records or regulator-backed public registration data.
How nifedipine is taken
MedlinePlus describes extended-release nifedipine as once daily and advises swallowing extended-release tablets whole rather than splitting, chewing or crushing them. Exact food instructions can vary by product, so patients should follow the leaflet for the formulation supplied. [1]
Side effects
Nifedipine can cause headache, flushing, dizziness, ankle swelling, palpitations and other effects related to vasodilation. Marked dizziness, fainting, worsening chest pain or signs of a severe allergic reaction need clinical assessment. Product-specific adverse effects and precautions should be checked in the actual label. [1]
Warnings and precautions
Low blood pressure · edema · headache · formulation-specific dosing. Product-specific contraindications and precautions should be checked before use.
Interactions and precautions
Nifedipine can interact with other medicines that affect blood pressure or drug metabolism. Because formulations and indications vary, medication review is important when nifedipine is started, stopped or changed. [1]
Pregnancy & breastfeeding
NHS guidance notes that nifedipine can be used in pregnancy when clinically appropriate and is usually compatible with breastfeeding. Individual indication and formulation still matter.
Overdose and accidental extra doses
Overdose can cause severe low blood pressure and cardiovascular instability. Suspected overdose requires emergency or poison-centre guidance.
Common questions
Frequently asked questions
Yes. Hypertension is one of its main uses.
Generally no. Extended-release tablets should be swallowed whole unless the specific product says otherwise.
No. It is a calcium-channel blocker.
Long-acting nifedipine is used to control angina over time, not as a rapid rescue treatment for an acute attack.
No. Release systems and instructions differ, so substitutions should be checked by a clinician or pharmacist.
Sources
Clinical statements in this reference are linked to named public-health, regulatory or guideline sources.
- 1. MedlinePlus. Nifedipine Drug Information. Source ↗
- 2. DailyMed. Nifedipine extended-release tablets prescribing information, updated 2026. Source ↗
- 3. NHS. About nifedipine and current patient guidance. Source ↗
This medicine reference is based on trusted medical and regulatory sources and is awaiting clinician review. It is not a substitute for personalized medical advice.